doi: 10.1093/jnci/djq017.
Epub 2010 Jan 27.
Japan works to shorten "drug lag," boost trials of new drugs
- PMID: 20107160
- DOI: 10.1093/jnci/djq017
Item in Clipboard
Japan works to shorten "drug lag," boost trials of new drugs
J Natl Cancer Inst.
.
No abstract available
Similar articles
-
Can single-patient investigational new drug studies hurry slow trains to the fast track?Drug Discov Today. 2006 Mar;11(5-6):185-6. doi: 10.1016/S1359-6446(05)03707-4. Drug Discov Today. 2006. PMID: 16580594
-
The role of the National Cancer Institute in drug development.Clin Adv Hematol Oncol. 2005 Apr;3(4):257-8. Clin Adv Hematol Oncol. 2005. PMID: 16166997 No abstract available.
-
New office and new leader aim to streamline FDA cancer drug review process.J Natl Cancer Inst. 2005 May 18;97(10):708-9. doi: 10.1093/jnci/97.10.708. J Natl Cancer Inst. 2005. PMID: 15900036 No abstract available.
-
[Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].Ugeskr Laeger. 2003 Apr 14;165(16):1649-52. Ugeskr Laeger. 2003. PMID: 12756820 Review. Danish.
-
[Present strategy for new drug development in the USA].Gan To Kagaku Ryoho. 1994 Oct;21 Suppl 3:315-24. Gan To Kagaku Ryoho. 1994. PMID: 7986110 Review. Japanese.
Cited by
-
Differences in maximum tolerated doses and approval doses of molecularly targeted oncology drug between Japan and Western countries.Invest New Drugs. 2014 Aug;32(4):661-9. doi: 10.1007/s10637-014-0080-y. Epub 2014 Mar 11. Invest New Drugs. 2014. PMID: 24615632
-
Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries.PLoS One. 2016 Feb 5;11(2):e0148455. doi: 10.1371/journal.pone.0148455. eCollection 2016. PLoS One. 2016. PMID: 26848574 Free PMC article.
-
Effectiveness and safety of an extended-release tablet of sodium valproate for the prophylactic treatment of migraine: Postmarketing surveillance in Japan.Neurol Clin Neurosci. 2016 Jul;4(4):134-141. doi: 10.1111/ncn3.12053. Epub 2016 Apr 26. Neurol Clin Neurosci. 2016. PMID: 27818772 Free PMC article.
-
Approval gap of pharmacogenomic biomarkers and in vitro companion diagnostics between the United States and Japan.J Clin Pharm Ther. 2014 Apr;39(2):210-4. doi: 10.1111/jcpt.12129. Epub 2014 Jan 10. J Clin Pharm Ther. 2014. PMID: 24405254 Free PMC article.
-
Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?Int J Clin Oncol. 2015 Dec;20(6):1072-80. doi: 10.1007/s10147-015-0825-4. Epub 2015 Apr 3. Int J Clin Oncol. 2015. PMID: 25837976
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
